HELIUS MED TECHNOLOGIES INC's ticker is HSDTXXXX and the CUSIP is 42328V504. A total of 35 filers reported holding HELIUS MED TECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $35,000 | – | 15,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rovida Advisors Inc. | 1,292,690 | $552,000 | 0.05% |
| Camelot Portfolios, LLC | 90,000 | $38,000 | 0.02% |
| ISTHMUS PARTNERS, LLC | 204,829 | $87,000 | 0.02% |
| Verdence Capital Advisors LLC | 28,010 | $12,000 | 0.00% |
| Good Life Advisors, LLC | 10,811 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 46,992 | $20,000 | 0.00% |
| UBS Group AG | 180 | $0 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 15 | $6,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 20 | $0 | 0.00% |